Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) EBT (2020 - 2025)

Celularity has reported EBT over the past 6 years, most recently at -$23.1 million for Q3 2025.

  • Quarterly results put EBT at -$23.1 million for Q3 2025, down 43.35% from a year ago — trailing twelve months through Sep 2025 was -$80.6 million (down 130.14% YoY), and the annual figure for FY2024 was -$57.9 million, up 70.51%.
  • EBT for Q3 2025 was -$23.1 million at Celularity, up from -$24.5 million in the prior quarter.
  • Over the last five years, EBT for CELU hit a ceiling of $49.9 million in Q3 2021 and a floor of -$93.9 million in Q3 2023.
  • Median EBT over the past 5 years was -$19.8 million (2025), compared with a mean of -$21.4 million.
  • Biggest five-year swings in EBT: surged 708.13% in 2022 and later crashed 2063.11% in 2023.
  • Celularity's EBT stood at -$4.0 million in 2021, then surged by 708.13% to $24.4 million in 2022, then crashed by 60.91% to $9.6 million in 2023, then tumbled by 239.09% to -$13.3 million in 2024, then tumbled by 73.6% to -$23.1 million in 2025.
  • The last three reported values for EBT were -$23.1 million (Q3 2025), -$24.5 million (Q2 2025), and -$19.8 million (Q1 2025) per Business Quant data.